| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 03/21/2013 | CA2847091A1 Compositions and methods for treating cancer using pi3k.beta. inhibitor and mapk pathway inhibitor, including mek and raf inhibitors |
| 03/21/2013 | CA2845806A1 Formulations of histone deacetylase inhibitor in combination with bendamustine and uses thereof |
| 03/21/2013 | CA2845673A1 Pharmaceutical nanoparticle compositions |
| 03/21/2013 | CA2844704A1 Aminopyrimidine derivatives for use as modulators of kinase activity |
| 03/20/2013 | EP2570436A1 Use of neutralizing prolactin receptor antibodies in combined hormone therapy |
| 03/20/2013 | EP2570435A1 Use of neutralizing prolactin receptor antibodies for the treatment of endometriosis and andenomyosis |
| 03/20/2013 | EP2570430A2 Peptide vaccines with Seq ID No: 78, 41, 44, 46 or 48 for cancers expressing tumor-associated antigens |
| 03/20/2013 | EP2570429A2 Peptide vaccines with Seq ID No: 48, 41, 44, 46 or 78 for cancers expressing tumor-associated antigens |
| 03/20/2013 | EP2570428A2 Peptide vaccines with Seq ID No: 379 or 376 for cancers expressing tumor-associated antigens |
| 03/20/2013 | EP2570137A2 Antibodies that bind human dendritic and epithelial cell 205 (DEC-205) |
| 03/20/2013 | EP2570136A2 Protein A compositions and methods of use |
| 03/20/2013 | EP2570132A2 Method for preparing novel processed ginseng or an extract thereof, the usually minute ginsenoside content of which is increased |
| 03/20/2013 | EP2570127A1 Compositions and methods for treating cancer using PI3KB beta inhibitor and MAPK pathway inhibitor, including MEK and RAF inhibitors |
| 03/20/2013 | EP2570121A1 Slow release tablet of elemene anti-tumor plant medicine |
| 03/20/2013 | EP2569633A2 Compositions and methods of identifying tumor specific neoantigens |
| 03/20/2013 | EP2569436A2 Recombinant hcmv and rhcmv vectors and uses thereof |
| 03/20/2013 | EP2569434A2 Compositions and methods for treating leukemia |
| 03/20/2013 | EP2569336A1 Enhanced death receptor agonists |
| 03/20/2013 | EP2569327A1 Eif4e binding peptides |
| 03/20/2013 | EP2569326A2 Peptide-based inhibitor of interleukin-10 or interferon-gamma signaling |
| 03/20/2013 | EP2569316A1 Pyrrolopyridine and pyrrolopyrimidine inhibitors of kinases |
| 03/20/2013 | EP2569315A1 Fused bicyclic kinase inhibitors |
| 03/20/2013 | EP2569314A1 Fused bicyclic kinase inhibitors |
| 03/20/2013 | EP2569313A1 Compounds useful as inhibitors of atr kinase |
| 03/20/2013 | EP2569312A1 Substituted heterocyclyl benzyl pyrazoles, and use thereof |
| 03/20/2013 | EP2569301A1 Indazole inhibitors of kinase |
| 03/20/2013 | EP2569292A1 Polysubstituted benzofurans and medicinal applications thereof |
| 03/20/2013 | EP2569290A2 Pharmaceutical compounds |
| 03/20/2013 | EP2569289A1 Pyrazines useful as inhibitors of atr kinase |
| 03/20/2013 | EP2569284A1 2 -aminopyridine derivatives useful as inhibitors of atr kinase |
| 03/20/2013 | EP2569016A1 Pharmaceutical compositions comprising antisense oligonucleotides and methods of using same |
| 03/20/2013 | EP2569014A1 Treatment methods |
| 03/20/2013 | EP2569012A2 Anti-fgfr2 antibodies |
| 03/20/2013 | EP2569011A1 Gep antibody and uses thereof |
| 03/20/2013 | EP2569006A2 The n-domain of carcinoembryonic antigen and compositions, methods and uses thereof |
| 03/20/2013 | EP2568996A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-beta-trna synthetases |
| 03/20/2013 | EP2568984A1 Compounds useful as inhibitors of atr kinase |
| 03/20/2013 | EP2568979A2 Ratiometric combinatorial drug delivery |
| 03/20/2013 | EP2568978A2 Cancer prevention and treatment methods based on dietary polyamine content |
| 03/20/2013 | EP2568962A1 A sustained release formulation of methotrexate as a disease-modifying antirheumatic drug (dmard) and an anti-cancer agent |
| 03/20/2013 | EP1303259B1 Prolonged release microspheres for injection delivery and preparation method |
| 03/20/2013 | CN1606554B Beta-lactamyl vasopressin v1a antagonists |
| 03/20/2013 | CN1571834B Cell therapy method for the treatment of tumors |
| 03/20/2013 | CN1541107B Growth factor complex |
| 03/20/2013 | CN102985557A Methods and compositions for cell-proliferation-related disorders |
| 03/20/2013 | CN102985423A Crystalline forms of a purine derivative |
| 03/20/2013 | CN102985422A Pyrrolopyridine and pyrrolopyrimidine inhibitors of kinases |
| 03/20/2013 | CN102985421A Naphthridine derivatives as pi3k inhibitors for the treatment of cancer and immune - inflammatory diseases |
| 03/20/2013 | CN102985420A Cytochrome P450 inhibitors and uses thereof |
| 03/20/2013 | CN102985413A Tricarbonyl technetium-99m or rhenium-188 label ring RGD derivative, a preparation method thereof, and a pharmaceutical composition containing the derivative as an active ingredient for use in the diagnosis or treatment of angiogenesis-related diseas |
| 03/20/2013 | CN102985410A Combretastatin analogs for use in the treatment of cancer |
| 03/20/2013 | CN102985405A Heterocyclic compound, and p27 kip1 degradation inhibitor |
| 03/20/2013 | CN102985402A Tranylcypromine derivatives as inhibitors of histone demethylase LSD1 and/or LSD2 |
| 03/20/2013 | CN102985113A Compositions and methods for the diagnosis and treatment of tumor |
| 03/20/2013 | CN102985111A Gep antibody and uses thereof |
| 03/20/2013 | CN102985109A Homodimeric protein constructs |
| 03/20/2013 | CN102985103A Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of p38 multi-tRNA synthetase complex |
| 03/20/2013 | CN102985095A Immunostimulatory and vaccine compositions |
| 03/20/2013 | CN102985094A Recombinant tumor vaccine and method of producing such vaccine |
| 03/20/2013 | CN102985093A Agent for suppressing the formation of abnormal skin cells caused by exposure to light |
| 03/20/2013 | CN102985089A Sigma ligands for the prevention and/or treatment of emesis induced by chemotherapy or radiotherapy |
| 03/20/2013 | CN102985088A Improved treatment of renal cell carcinoma |
| 03/20/2013 | CN102985086A Methods of enhancing drug delivery and effectiveness of therapeutic agents |
| 03/20/2013 | CN102978713A Leukemia single-chain antibody library, as well as construction method and application thereof |
| 03/20/2013 | CN102978278A Endogenous non-coding micro RNAs and uses thereof |
| 03/20/2013 | CN102978277A Assays and methods using biomarkers |
| 03/20/2013 | CN102977413A New method for preparing micelles by compounding polymers |
| 03/20/2013 | CN102977360A Triphenylphosphine-polyethyleneglycol 1000 vitamin E succinate (TPGS 1000-TPP) conjugated compound, and preparation method and application thereof |
| 03/20/2013 | CN102977221A Preparation method of coix seed polysaccharide and application of coix seed polysaccharide |
| 03/20/2013 | CN102977218A Method for extracting polysaccharide from buckwheat brans |
| 03/20/2013 | CN102977212A Compositions comprising anti-IGF-1r antibodies and methods for their production |
| 03/20/2013 | CN102977203A Epithelial cell division chalone, and preparation method and application thereof |
| 03/20/2013 | CN102977188A GNRH (gonadotropin-releasing hormone) peptide variants |
| 03/20/2013 | CN102977175A Application of glucosamine derivatives as small molecule drug kidney-targeting modifying groups |
| 03/20/2013 | CN102977145A Phosphoinositide compounds and their preparation method and use |
| 03/20/2013 | CN102977126A Dual-indolizine substitutive derivative as well as preparation method and use thereof |
| 03/20/2013 | CN102977125A 2,7-naphthyridine derivative, and preparation method and application thereof |
| 03/20/2013 | CN102977114A Inoscavin A as a monomeric component in phellinus as well as prepearation method and application thereof |
| 03/20/2013 | CN102977110A Asymmetric dendritic metalloporphyrin as well as preparation method and application thereof |
| 03/20/2013 | CN102977107A Pemetrexed disodium compound and composition thereof |
| 03/20/2013 | CN102977098A Aryl-substituted indolizine derivative and preparation method and applications thereof |
| 03/20/2013 | CN102977097A Aryne-based substituted indolizine derivative and preparation method and applications thereof |
| 03/20/2013 | CN102977096A Harmine derivative anti-tumor prodrug with target characteristic |
| 03/20/2013 | CN102977095A Pyrroloquinolines compound and application thereof |
| 03/20/2013 | CN102977092A Application of aromatic alkanoyl tetrahydro-beta-carboline and derivative thereof in treatment of cancer |
| 03/20/2013 | CN102977082A Isocoumarin compound as well as preparation method and application thereof |
| 03/20/2013 | CN102977081A Homopiperony lamine pyridine -2- formaldehyde and synthetic method and application thereof |
| 03/20/2013 | CN102977065A Flavonoid compound and preparation method and application thereof |
| 03/20/2013 | CN102977062A Magnolol compound as well as preparation method and application of magnolol compound |
| 03/20/2013 | CN102977059A Phenylpropanoid compound, and preparation method and application thereof |
| 03/20/2013 | CN102977038A Bis(2-acetylpyrazine) thiocarbonohydrazone and preparation method and application of bismuth (III) complex thereof |
| 03/20/2013 | CN102977019A New C19 diterpenoid alkaloid in Aconitum hemsleyanum var. janyuanum and applications thereof in preparation of anticancer drugs |
| 03/20/2013 | CN102977018A Application of indenoindene isoquinoline estrogen receptor beta adjustment agent in resisting breast cancer |
| 03/20/2013 | CN102977014A New quinoline compounds and uses thereof |
| 03/20/2013 | CN102976928A Compounds for reducing uric acid |
| 03/20/2013 | CN102973950A PRAME and WT1 bivalent tumor DNA vaccine |
| 03/20/2013 | CN102973949A Preparation method for alpha-TOS-loaded and dendrimer-wrapped gold nanoparticles |
| 03/20/2013 | CN102973947A Antibody-drug conjugates and methods |
| 03/20/2013 | CN102973945A Trypsin-regulated nanometer supramolecular vesicles and preparation method and application thereof |
| 03/20/2013 | CN102973941A Polymer hydrogel loading chemotherapy drug, and application thereof in preventing tumor recurrence and preventing and treating postoperative abdominal adhesion |